Antileishmanial agent-4
Antileishmanial agent-4 is a ribonucleoside analogue and acts as an antileishmanial agent[1].
Product Specifications
CAS Number
[2922333-23-9]
UNSPSC
12352005
Target
Parasite
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/antileishmanial-agent-4.html
Solubility
10 mM in DMSO
Smiles
CC1=NC=NC2=C1C(C3=NC=CC=C3)=CN2[C@@H]4O[C@@H]([C@H]([C@H]4O)O)CO
Molecular Formula
C17H18N4O4
Molecular Weight
342.35
References & Citations
[1]Cai Lin, et al. Exploration of 6-methyl-7- (Hetero) Aryl-7-Deazapurine ribonucleosides as antileishmanial agents. Eur J Med Chem
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
Leishmania
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS2553252-01 0.01 mg
Recombinant Human ST6 Sialyltransferase 2/ST6GalNAc2 Protein (C-6His)
Ask
View Details 
MBS2553252-02 0.05 mg
Recombinant Human ST6 Sialyltransferase 2/ST6GalNAc2 Protein (C-6His)
Ask
View Details 
MBS2553252-03 5x 0.05 mg
Recombinant Human ST6 Sialyltransferase 2/ST6GalNAc2 Protein (C-6His)
Ask
View Details 035809-AP 200 µL
FXN, NT (FXN, FRDA, X25, Frataxin, mitochondrial, Friedreich ataxia protein, Frataxin intermediate form, Frataxin (56-210), m56-FXN, Frataxin (78-210), d-FXN, m78-FXN, Frataxin mature form, Frataxin (81-210), m81-FXN) (AP) discontinued
Ask
View Details